HomeBCLI • NASDAQ
Brainstorm Cell Therapeutics Inc
add
$1.13
0.00%
Pre-market:(1.77%)+0.020
$1.15
Closed: Jun 6, 8:31:53 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.09M | 24.86% |
Net income | -2.86M | 15.79% |
Net profit margin | — | — |
Earnings per share | -0.45 | — |
EBITDA | -3.03M | -25.68% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.64M | 111.04% |
Total assets | 3.57M | 6.66% |
Total liabilities | 11.03M | 23.94% |
Total equity | -7.46M | — |
Shares outstanding | 7.91M | — |
Price to book | -1.20 | — |
Return on assets | -285.86% | — |
Return on capital | 124.25% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.86M | 15.79% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$1.13
Year range
$0.72 - $8.09
Market cap
8.97M USD
Avg Volume
2.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2000
Website
Employees
27
